Article · Revue · 2021

Ivermectin shows clinical benefits in mild to moderate COVID19: a randomized controlled double-blind, dose-response study in Lagos

O. E. Babalola, Christopher O. Bode, Akintayo Micheal Ajayi, Felix Alakaloko, Iorhen E. Akase, Erere Otrofanowei et 4 autres

QJM

• Accès ouvert · Bronze
• Top 10 % mondial
• International · 2 pays

Le lire10.1093/qjmed/hcab035